[{"Assets_0_Q1_USD":"11400700000.0","CIK":"1585364","CommonStockDividendsPerShareDeclared_1_Q1_USD":"0.23","CommonStockSharesConverted_0_Q1_shares":"136300000.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"0.78","EarningsPerShareDiluted_1_Q1_USD":"0.77","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"4754722726.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"171800000.0","NetIncomeLossConverted_1_Q1_USD":"106400000.0","OfficialName":"Perrigo Company plc Ordinary Shares","RevenuesConverted_1_Q1_USD":"1341000000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"5786900000.0","StockholdersEquity_0_Q1_USD":"5786400000.0","Ticker":"PRGO","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"137300000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"136200000.0","filed":"20200505","footnote":null,"form":"10-Q","fp":"Q1","fy":"2020.0","name":"PERRIGO CO PLC","period":"20200331","qtrs":"0","uom":"USD"}]